Bitopertin is an investigational atypical antipsychotic agent that acts as a glycine transporter 1 (GlyT1) inhibitor and is primarily studied in clinical trials for the treatment of conditions such as… Read more
Bitopertin is an investigational atypical antipsychotic agent that acts as a glycine transporter 1 (GlyT1) inhibitor and is primarily studied in clinical trials for the treatment of conditions such as schizophrenia and obsessive-compulsive disorder. This category provides access to high-quality analytical tools for researchers and pharmaceutical laboratories, including Bitopertin reference standards, known impurities, and metabolites. Laboratories rely on these materials for critical tasks such as impurity profiling, the validation of analytical methods, and routine quality control testing. Furthermore, stable isotope labelled compounds like Bitopertin-d8 are essential for precise quantification in mass spectrometry-based studies, allowing analysts to trace metabolic pathways and determine endogenous background levels with high accuracy. By utilizing these standardized materials, analytical teams can ensure regulatory compliance and maintain the integrity of their drug development and pharmacokinetic research.